Synapse - Raymond Comenzo

Results (115)

Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; more...
Blood (2004)

Fulltext@MSK | Save

Systemic AL amyloidosis due to non-Hodgkin's lymphoma: An unusual clinicopathologic association

Journal Article

Cohen, A. D.; Zhou, P.; Xiao, Q.; Fleisher, M.; Kalakonda, N.; Akhurst, T.; Chitale, D. A.; Moskowitz, C.; Dhodapkar, M. V.; Teruya-Feldstein, J.; more...
British Journal of Haematology (2004)

Fulltext@MSK | Save

CD20-negative large-cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV-positive and -negative patients

Journal Article

Teruya-Feldstein, J.; Chiao, E.; Filippa, D. A.; Lin, O.; Comenzo, R.; Coleman, M.; Portlock, C.; Noy, A.
Annals of Oncology (2004)

Fulltext@MSK | Save

CD 20 negative (-) large cell lymphoma with plasmablastic features: A heterogenous spectrum in both HIV+ and patients

Meeting Abstract

Teruya-Feldstein, J.; Lin, O.; Chiao, E.; Xiao, Q. X.; Filippa, D. A.; Coleman, M.; Comenzo, R.; Portlock, C. S.; Noy, A.
Blood (2003)

Fulltext@MSK | Save

A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma

Meeting Abstract

Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
Blood (2003)

Fulltext@MSK | Save

Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma